Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

105 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Structure and physical properties of single crystals of the 84-K superconductor Bi2.2Sr2Ca0.8Cu2O8+ delta.
Sunshine SA, Siegrist T, Schneemeyer LF, Murphy DW, Cava RJ, Batlogg B, van Dover RB, Fleming RM, Glarum SH, Nakahara S, Farrow R, Krajewski JJ, Zahurak SM, Waszczak JV, Marshall JH, Marsh P, Rupp LW Jr, Peck WF. Sunshine SA, et al. Among authors: marshall jh. Phys Rev B Condens Matter. 1988 Jul 1;38(1):893-896. doi: 10.1103/physrevb.38.893. Phys Rev B Condens Matter. 1988. PMID: 9945287 No abstract available.
Field-dependent microwave absorption in high-Tc superconductors.
Glarum SH, Marshall JH, Schneemeyer LF. Glarum SH, et al. Among authors: marshall jh. Phys Rev B Condens Matter. 1988 May 1;37(13):7491-7495. doi: 10.1103/physrevb.37.7491. Phys Rev B Condens Matter. 1988. PMID: 9944039 No abstract available.
Charge transfer at aluminum-C60 interfaces in thin-film multilayer structures.
Hebard AF, Eom CB, Iwasa Y, Lyons KB, Thomas GA, Rapkine DH, Fleming RM, Haddon RC, Phillips JM, Marshall JH, Eick RH. Hebard AF, et al. Among authors: marshall jh. Phys Rev B Condens Matter. 1994 Dec 15;50(23):17740-17743. doi: 10.1103/physrevb.50.17740. Phys Rev B Condens Matter. 1994. PMID: 9976205 No abstract available.
Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial.
Brown SM, Barkauskas CE, Grund B, Sharma S, Phillips AN, Leither L, Peltan ID, Lanspa M, Gilstrap DL, Mourad A, Lane K, Beitler JR, Serra AL, Garcia I, Almasri E, Fayed M, Hubel K, Harris ES, Middleton EA, Barrios MAG, Mathews KS, Goel NN, Acquah S, Mosier J, Hypes C, Salvagio Campbell E, Khan A, Hough CL, Wilson JG, Levitt JE, Duggal A, Dugar S, Goodwin AJ, Terry C, Chen P, Torbati S, Iyer N, Sandkovsky US, Johnson NJ, Robinson BRH, Matthay MA, Aggarwal NR, Douglas IS, Casey JD, Hache-Marliere M, Georges Youssef J, Nkemdirim W, Leshnower B, Awan O, Pannu S, O'Mahony DS, Manian P, Awori Hayanga JW, Wortmann GW, Tomazini BM, Miller RF, Jensen JU, Murray DD, Bickell NA, Zatakia J, Burris S, Higgs ES, Natarajan V, Dewar RL, Schechner A, Kang N, Arenas-Pinto A, Hudson F, Ginde AA, Self WH, Rogers AJ, Oldmixon CF, Morin H, Sanchez A, Weintrob AC, Cavalcanti AB, Davis-Karim A, Engen N, Denning E, Taylor Thompson B, Gelijns AC, Kan V, Davey VJ, Lundgren JD, Babiker AG, Neaton JD, Lane HC; ACTIV-3b/Therapeutics for Severely Ill Inpatients with COVID-19 (TESICO) Study Group. Brown SM, et al. Lancet Respir Med. 2023 Sep;11(9):791-803. doi: 10.1016/S2213-2600(23)00147-9. Epub 2023 Jun 19. Lancet Respir Med. 2023. PMID: 37348524 Clinical Trial.
105 results